文献速递肿瘤 PET/CT

FDG-PET/CT在多发性骨髓瘤中的临床价值:更新

Clinical Value of FDG-PET/CT in Multiple Myeloma: An Update.
PubMed 文献 · Semin Nucl Med · 2022-11-26

本文综述FDG-PET/CT在多发性骨髓瘤管理中的临床价值,指出其已被公认为疗效评估的金标准,并可提供分期和治疗后的预后指标。文章进一步讨论活跃病灶体积测量的预后价值与标准化问题、FDG阳性髓旁和髓外病变的意义、FDG阳性微小残留病的预后影响、局灶性病变与克隆异质性的关系,以及与全身DWI-MR在检测和疗效评估方面的比较。

要点

  • FDG-PET/CT已被公认为多发性骨髓瘤疗效评估的金标准。
  • FDG-PET/CT在分期和治疗后可提供多个预后指标。
  • 活跃病灶体积测量、FDG阳性髓旁和髓外病变、FDG阳性微小残留病等较新方面尚未具有临床影响。

核心结论

  • FDG-PET/CT已被公认为多发性骨髓瘤疗效评估的金标准,并可提供分期和治疗后的预后指标。

研究设计与样本

  • 本文为综述,检索范围未报告。

主要发现

  • FDG-PET/CT可深入评估疗效,并在分期和治疗后提供多个预后指标。
  • 已发表论文分析活跃病灶体积测量的预后价值与标准化问题。
  • 已发表论文分析FDG阳性髓旁和髓外病变的意义。
  • 已发表论文分析FDG阳性微小残留病的预后影响。
  • 已发表论文分析局灶性病变与该病克隆异质性的关系,以及与全身DWI-MR在检测和疗效评估方面的比较。

关键数值与推荐

  • 这些较新方面尚未具有临床影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

FDG-PET/CT is a standardized imaging technique that has reached a great importance in the management of patients affected by Multiple Myeloma. It is proved, in fact, that it allows a deep evaluation of therapy efficacy and provides several prognostic indexes both at staging and after therapy. For this reason, it is now recognised as a gold standard for therapy assessment. Beside this, in reacent years FDG-PET/CT contribution to the understanding of Multiple Myeloma has progressively grown. Papers have been published analyzing the prognostic value of active disease volume measurement and standardization issues, the meaning of FDG positive paramedullary and extrameduallary disease, the prognostic impact of FDG positive minimal residual disease, the relation between focal lesions and clonal eterogenity of this disease and the comparison with whole body DWI-MR in terms of detection and therapy assessment. These newer aspects not of clinical impact yet, of FDG-PET/CT in Multiple Myeloma will be presented and discussed in this review.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Bezzi D, Ambrosini V, Nanni C, et al. Clinical Value of FDG-PET/CT in Multiple Myeloma: An Update. Semin Nucl Med. 2022. PMID: 36446644. doi:10.1053/j.semnuclmed.2022.10.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。